Products for Research Use Only
RegisterLogin

SMU-B

CAT: 0804-HY-120387Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-120387Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SMU-B is the orally active inhibitor for ALK (IC50c-ros oncogene 1 (ROS1), c-MET (IC50=1.87 nM) and AXL (IC50=28.9 nM) . SMU-B inhibits the proliferation of MKN45, H1993 and H441 with IC50s of 0.02 μM, 1.58 μM and 2.82 μM, respectively. SMU-B exhibits antitumor efficacy in mouse models[1][2].
CAS Number
1253286-90-6
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK) ; c-Met/HGFR; ROS Kinase; TAM Receptor
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/smu-b.html
Smiles
O=C1NC2=C(C=CC(C3=CC(O[C@@H](C4=C(Cl)C=CC(F)=C4Cl)C)=C(N)N=C3)=C2)C15CCN(C)CC5
Molecular Formula
C26H25Cl2FN4O2
Molecular Weight
515.41
References & Citations
[1]Tian Y, et al., Molecular Simulation Studies on the Binding Selectivity of Type-I Inhibitors in the Complexes with ROS1 versus ALK. J Chem Inf Model. 2017 Apr 24;57 (4) :977-987.|[2]Li J, et al., Aminopyridyl/Pyrazinyl Spiro[indoline-3,4'-piperidine]-2-ones As Highly Selective and Efficacious c-Met/ALK Inhibitors. ACS Med Chem Lett. 2013 Jul 12;4 (8) :806-10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-N12110-01SMU-CX1
HY-157793-01SMU-L11
HY-176192SMU-14a
HY-178391SMU-037
HY-175782SMU-R39
HY-175769SMU-V18
HY-175293SMU-C68
HY-172907SMU-1k
HY-179047SMU-L11-R
HY-P991290-01IRAB-B

Alternative Products

CatalogName
MBS5774553SMU-B
T208970-01SMU-L11
GTR19264428-01SMU-C68
GTR19257765-01SMU-1k
T207268-01SMU-14a
GTR19274872-01SMU-C409
GTR19273679-01SMU-037
GTR19272985-01SMU-V18
GTR19272886-01SMU-R39
T8460SMU-MFS Cells

Popular Products